Skip to main content
Log in

Valproate metabolites in the rat brain — regional distribution in various brain areas

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

To investigate the regional distribution of valproic acid (VPA) and 10 of its metabolites in the rat brain, the animals were treated with 300 mg/kg/day VPA i.p. on a 3 times daily dose regimen for 5 days, and the concentrations of the compounds in serum and 15 brain regions were measured. 2-(n-propyl)-(Z)-2-pentenoic acid [(Z)-2-en], a VPA metabolite expected to possess neurotoxic potency in humans, was determined in brain tissue for the first time. The brain/serum concentration ratio of (Z)-2-en was found to be about 14-fold higher than the ratio for its (E)-isomer, thereby demonstrating the influence of the double-bond configuration in the unsaturated metabolites on their ability to penetrate into the central nervous system. The concentrations of VPA and its metabolites in the brain regions were compared to chom, the calculated concentration for an assumed homogeneous distribution. The parent drug and its metabolites exhibited individual distribution patterns with varying degrees of inhomogeneity. Elevated metabolite concentrations were found especially in the motorium and the medulla oblongata. Decreased concentrations of VPA and several metabolites were found in the visual cortex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bourgeois B.F.D. (1995): Valproic acid — clinical use. In: Levy R.H., Mattson R.H., Meldrum B.S. (Eds.) Antiepileptic drugs, 4th edn. New York: Raven, 633–639.

    Google Scholar 

  2. Richens A., Davidson D.L.W., Cartlidge N.E.F., Easter D.J. (1994): A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J. Neurol. Neurosurg. Psychiatr., 57: 682–687.

    Article  PubMed  CAS  Google Scholar 

  3. Baillie T.A., Sheffels P.R. (1995): Valproic acid — chemistry and biotransformation. In: Levy R.H., Mattson R.H., Meldrum B.S. (Eds). Antiepileptic drugs; 4th edn. New York: Raven, 589–604.

    Google Scholar 

  4. Löscher W. (1981): Anticonvulsant activity of metabolites of valproic acid. Arch. Int. Pharmacodyn. Ther., 249: 158–163.

    PubMed  Google Scholar 

  5. Löscher W., Nau H. (1985): Pharmacological evaluation of various metabolites and analogues of valproic acid: anticonvulsant and toxic potencies in mice. Neuropharmacology, 24: 427–435.

    Article  PubMed  Google Scholar 

  6. Abbott F.S., Acheampong A.A. (1988): Quantitative structure-anticonvulsant activity relationship of valproic acid, related carboxylic acids and tetrazoles. Neuropharmacology, 27: 287–294.

    Article  PubMed  CAS  Google Scholar 

  7. Elmazar M.M.A., Hauck R.-S., Nau H. (1993): Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid. J. Pharm. Sci., 82: 1255–1258.

    Article  PubMed  CAS  Google Scholar 

  8. Hönack D., Rundfeldt C., Löscher W. (1992): Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats. Naunyn-Schmiedebergs Arch. Pharmacol., 345: 187–196.

    Article  PubMed  Google Scholar 

  9. Palaty J., Abbott F.S. (1995): Structure-activity relationship of unsaturated analogues of valproic acid. J. Med. Chem., 38: 3398–3406.

    Article  PubMed  CAS  Google Scholar 

  10. Schmidt A., Darius J., Brosz M.et al. (1995): The influence of valproic acid monotherapy on behavior and cognitive performance in children with idiopathic generalized epilepsy. Z. Kinder-Jugendpsychiatr., 23: 161–170.

    PubMed  CAS  Google Scholar 

  11. Rohlfs A., Rundtfeldt C., Koch R., Löscher W. (1996): A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats. J. Pharmacol. Exp. Ther., 277: 1305–1314.

    PubMed  CAS  Google Scholar 

  12. Adkison K.D.K., Ojemann G.A., Rapport R.L., Dills R.L., Shen D.D. (1995): Distribution of unsaturated metabolites of valproate in human and rat brain — pharmacological relevance? Epilepsia, 36: 772–782.

    Article  PubMed  CAS  Google Scholar 

  13. Löscher W., Fisher J.E., Nau H., Hönack D. (1989): Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment. J. Pharmacol. Exp. Ther., 250: 1067–1078.

    PubMed  Google Scholar 

  14. Darius J., Meyer F.P. (1996): Concentrations of valproate metabolites under therapeutic conditions. Exp. Toxicol. Pathol., 48: 87–91.

    Google Scholar 

  15. Löscher W., Fisher J.E., Nau H., Hönack D. (1988): Marked increase in anticonvulsant activity but decrease in wet-dog shake behavior during short-term treatment of amygdala-kindled rats with valproic acid. Eur. J. Pharmacol., 150: 221–232.

    Article  PubMed  Google Scholar 

  16. Popov N., Pohle W., Lössner B.et al. (1973): Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labeled precursors. Acta Biol. Med. Germ., 31: 51–62.

    PubMed  CAS  Google Scholar 

  17. Nau H., Löscher W. (1982): Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and γ-aminobutyric acid (GABA) metabolism in the mouse. J. Pharmacol. Exp. Ther., 220: 654–659.

    PubMed  CAS  Google Scholar 

  18. Löscher W., Nau H. (1983): Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment. J. Pharmacol. Exp. Ther., 226: 845–854.

    PubMed  Google Scholar 

  19. Yu D., Gordon J.D., Zheng J.et al. (1995): Determination of valproic acid and its metabolites using gas chromatography with mass-selective detection: application to serum and urine samples from sheep. J. Chromatogr. B Biomed. Appl., 666: 269–281.

    Article  PubMed  CAS  Google Scholar 

  20. Darius J. (1996): On-column gas chromatographic-mass spectrometric assay for metabolic profiling of valproate in brain tissue and serum. J. Chromatogr. B Biomed. Appl., 682: 67–72.

    Article  PubMed  CAS  Google Scholar 

  21. Frey H-H., Löscher W. (1978): Distribution of valproate across the interface between blood and cerebrospinal fluid. Neuropharmacology, 17: 637–642.

    Article  PubMed  CAS  Google Scholar 

  22. Adkison K.D., Shen D.D. (1996): Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J. Pharmacol. Exp. Ther., 276: 1189–1200.

    PubMed  CAS  Google Scholar 

  23. Hoeppner TJ. (1990): The anticonvulsant valproic acid concentrates in the olfactory bulb: selective laminar localization. Brain Res., 532: 326–328.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Darius, J., Meyer, F.P., Bergsträsser, E. et al. Valproate metabolites in the rat brain — regional distribution in various brain areas. Eur. J. Drug Metab. Pharmacokinet. 24, 97–104 (1999). https://doi.org/10.1007/BF03190017

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190017

Keywords

Navigation